NovaBay Pharmaceuticals, Inc. Shareholders Equity per Share

Shareholders Equity per Share of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity per Share growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity per Share for the quarter ending June 30, 2022 was 0.3 (a -15.72% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity per Share increased by 43.21%
  • Annual Shareholders Equity per Share for 2021 was 0.23 (a -33.66% decrease from previous year)
  • Annual Shareholders Equity per Share for 2020 was 0.35 (a 680.44% increase from previous year)
  • Annual Shareholders Equity per Share for 2019 was 0.05 (a -84.63% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity per Share of NovaBay Pharmaceuticals, Inc.

Most recent Shareholders Equity per Shareof NBY including historical data for past 10 years.

Interactive Chart of Shareholders Equity per Share of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Shareholders Equity per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.3 0.35
2021 0.22 0.21 0.26 0.26 0.23
2020 0.35 0.35 0.03 -0.01 0.35
2019 0.05 0.15 0.09 0.07 0.05
2018 0.29 0.35 0.43 0.54 0.29
2017 0.17 0.12 0.21 0.29 0.17
2016 0.75 0.62 -0.33 -1.79 0.75
2015 -1.83 0.08 1.85 0.99 -1.83
2014 0.93 2.8 4.54 6.53 0.93
2013 5.58 3.62 4.84 7.03 5.58
2012 11.93 6.45 4.89 6.45 11.93
2011 9.06 11.6 9.06

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology